Readers, if you have some amount of money (I doubt it, but anyway) and thinking where to invest, read this or just read this post.
After 30 years of research, many regenerative medicine technologies are in development and approaching commercialization.
The main force driving the growth of the regenerative medicine market is both compelling and well known: demographic trends are putting pressure on healthcare. The U.S. alone spent an estimated $2.2T, or 16% of GDP, on healthcare in 2006 – a number that is expected to reach $4.1T by 2016. In this context, it is not surprising that the current market for regenerative medicines is $3.6B and growing. Conservative estimates suggest that the global market for regenerative medicine will reach between $11.5B to $20B by 2010 with a projected CAGR of 27.5%. U.S. sales of commercially available stem cell therapies alone were already $10M in the first half of 2007.
I like this model from the Report:
Very good analysis of perspectives!
You can download it for free after registration.